Skip to main content
. 2020 May 21;64(6):e02050-19. doi: 10.1128/AAC.02050-19

FIG 2.

FIG 2

MALDI-TOF MS data of TL17 and TL19 before (blue) and after (red) treatment with CDAP. (a) TL17; (b) TL19; (c) hypothetical structure of TL19.